Literature DB >> 14597993

ADAMTS 13 genotype and vWF protease activity in an Italian family with TTP.

Giovanna Bestetti1, Alessia Stellari, Antonella Lattuada, Mario Corbellino, Carlo Parravicini, Cinzia Calzarossa, Salvatore Cenzuales, Mauro Moroni, Massimo Galli, Edoardo Rossi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14597993     DOI： 10.1160/TH03-03-0150

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  7 in total

Review 1.  ADAMTS13 and microvascular thrombosis.

Authors:  Han-Mou Tsai
Journal:  Expert Rev Cardiovasc Ther       Date:  2006-11

2.  Enzymatically active ADAMTS13 variants are not inhibited by anti-ADAMTS13 autoantibodies: a novel therapeutic strategy?

Authors:  Wenhua Zhou; Lingli Dong; David Ginsburg; Eric E Bouhassira; Han-Mou Tsai
Journal:  J Biol Chem       Date:  2005-10-03       Impact factor: 5.157

Review 3.  The molecular biology of thrombotic microangiopathy.

Authors:  H-M Tsai
Journal:  Kidney Int       Date:  2006-05-31       Impact factor: 10.612

Review 4.  Pathophysiology of thrombotic thrombocytopenic purpura.

Authors:  Han-Mou Tsai
Journal:  Int J Hematol       Date:  2010-01       Impact factor: 2.490

Review 5.  The kidney in thrombotic thrombocytopenic purpura.

Authors:  H-M Tsai
Journal:  Minerva Med       Date:  2007-12       Impact factor: 4.806

Review 6.  Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children.

Authors:  Chantal Loirat; Jean-Pierre Girma; Céline Desconclois; Paul Coppo; Agnès Veyradier
Journal:  Pediatr Nephrol       Date:  2008-06-24       Impact factor: 3.714

Review 7.  Proteolytic processing of von Willebrand factor by adamts13 and leukocyte proteases.

Authors:  Stefano Lancellotti; Maria Basso; Raimondo De Cristofaro
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-09-02       Impact factor: 2.576
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.